Use of the wearable cardioverter-defibrillator – the Swiss experience
Boldizsar Kovacs(University of Bern), Fırat Duru(University of Zurich), Laurent Roten(University of Bern), Urs Eriksson(University of Zurich), Jan Berg(Kantonsspital Aarau), Richard Kobza(Leipzig Heart Institute), Roman Brenner(Kantonsspital St. Gallen), Jan Steffel(Zurich Heart House), Ardan M. Saguner(Zurich Heart House), Giulia Domenichini(University of Lausanne), Jürg Schläpfer, Haran Burri, Beat Schaer(University of Basel), Nazmi Krasniqi(GZO Spital Wetzikon), A. Linka(Kantonsspital Winterthur), Laurent Haegeli(Zurich Heart House), Christian Sticherling(Sichuan University), Christian Grebmer(Luzerner Kantonsspital), Tobias Reichlin(University of Bern), Andreas S. Müller(Triemli Hospital), Kurt Mayer(Kantonsspital Graubünden), Omer Dzemali(Triemli Hospital), Sven Reek(Hirslanden Klinik Aarau), Peter Ammann(Kantonsspital St. Gallen)
Cited by 14
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
|European Heart Journal|2018|2.1k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k